Sunhawk Vision Biotech, Inc.
視航生物醫學股份有限公司
Leave your email for change alerts (optional)
2019Founded
NT$703MPaid-in capital
0Plants
1Certifications
1Patents
< NT$20MRevenue band (est.)
- Unified Business No.
- 85009024
- Industry
- Tobacco Manufacturing (1,186)
- Listing
- Emerging stock (TPEx) (359) 7759
- Founded
- 2019-08-30
- Paid-in capital
- NT$ 703,421,590
- Phone
- 02-27114597
- Website
- https://www.sunhawkvision.com/
- Exporter
- Yes — registered with the Trade Administration
- Annual revenue band
- < NT$20M estimated
- Ownership
- Individually held
- Representative tenure
- In office since 2022-06 (4 yrs); last handover 2022-06
- Growth & profitability
- Revenue 2026-09 YoY —, year-to-date —
Certifications 1
- FDA (53)Self-reported
Patents 1
- 2023 Use of pharmaceutical composition for preparing medicament for ocular surface injury
Similar companies 10
- AuthenX Inc. Emerging stock (TPEx) < NT$20M
Shared: Other intellectual property leasing n.e.c. - PHARMOSA BIOPHARM INC. Listed (TPEx) NT$0.5–1B estimated
Shared: Other intellectual property leasing n.e.c., Other professional, scientific & technical services n.e.c. - MEDIGEN BIOTECHNOLOGY CORP. Listed (TPEx) NT$1–5B
Shared: FDA, Other professional, scientific & technical services n.e.c., Medical laboratory testing service - Precision Health Inc. Public company (unlisted) NT$100–500M
Shared: Other professional, scientific & technical services n.e.c., Medical laboratory testing service - OBIGEN PHARMA, INC. · Tainan City Emerging stock (TPEx) < NT$20M estimated
Shared: Other intellectual property leasing n.e.c., Other professional, scientific & technical services n.e.c., Medical laboratory testing service - TLC BioSciences Corp. Emerging stock (TPEx) NT$20–100M
Shared: FDA - Helixism Biomedical Inc. · New Taipei City < NT$20M estimated
Shared: FDA, Other professional, scientific & technical services n.e.c., Medical laboratory testing service - Yung Sheng Biotech Co., Ltd. Listed (TWSE) NT$100–500M
Shared: FDA - HEALTHCONN CORP. Emerging stock (TPEx) NT$1–5B
Shared: Medical laboratory testing service - ADVAGENE BIOPHARMA CO., LTD. Emerging stock (TPEx) NT$100–500M estimated
Shared: Other intellectual property leasing n.e.c.